Special Article
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
First published: 15 May 2001
Citations: 1,755
Abstract
Objective
To develop a standardized nomenclature system for the neuropsychiatric syndromes of systemic lupus erythematosus (NPSLE).
Methods
An international, multidisciplinary committee representing rheumatology, neurology, psychiatry, neuropsychology, and hematology developed case definitions, reporting standards, and diagnostic testing recommendations. Before and after the meeting, clinician committee members assigned diagnoses to sets of vignettes randomly generated from a pool of 108 NPSLE patients. To assess whether the nomenclature system improved diagnostic agreement, a consensus index was developed and pre- and postmeeting scores were compared by t-tests.
Results
Case definitions including diagnostic criteria, important exclusions, and methods of ascertainment were developed for 19 NPSLE syndromes. Recommendations for standard reporting requirements, minimum laboratory evaluation, and imaging techniques were formulated. A short neuropsychological test battery for the diagnosis of cognitive deficits was proposed. In the postmeeting exercise, a statistically significant improvement in diagnostic agreement was observed.
Conclusion
The American College of Rheumatology (ACR) Nomenclature for NPSLE provides case definitions for 19 neuropsychiatric syndromes seen in SLE, with reporting standards and recommendations for laboratory and imaging tests. It is intended to facilitate and enhance clinical research, particularly multicenter studies, and reporting. In clinical settings, consultation with other specialists may be required. It should be useful for didactic purposes but should not be used uncritically or as a substitute for a clinical diagnosis. The complete case definitions are available on the ACR World Wide Web site: http://www.rheumatology.org/ar/ar.html.
Supporting Information
| Filename | Description |
|---|---|
| anr2-sup-0001-Supinfo.docxWord document, 325.7 KB |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Hebra F, Kaposi M. On diseases of the skin including the exanthemata. Vol. IV. Tay W, editor/translator. London: The New Syndeham Society; 1875. p. 14–47.
- 2 Daly D. Central nervous system in acute disseminated lupus erythematosus. J Nerv Ment Dis 1945; 102: 461–4.
- 3 Clark EC, Bailey AA. Neurological and psychiatric signs associated with systemic lupus erythematosus. JAMA 1956; 160: 455–7.
- 4 Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. JAMA 1964; 190: 104–11.
- 5 Klippel JH, Zvaifler NJ. Neuropsychiatric abnormalities in systemic lupus erythematosus. Clin Rheum Dis 1975; 1: 621–38.
- 6 Sergent JS, Lockshin MD, Klemperer MS, Lispky BA. Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. Am J Med 1975; 58: 644–54.
- 7 Kaell AT, Shetty M, Lee BC, Lockshin MD. The diversity of neurologic events in systemic lupus erythematosus: prospective clinical and computed tomographic classification of 82 events in 71 patients. Arch Neurol 1986; 43: 273–6.
- 8 Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al, European Consensus Study Group for Disease Activity in SLE (1992). Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol 1992; 10: 527–39.
- 9 West SG, Emlen W, Werner MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10–year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153–63.
- 10 Boumpas DT, Austin HA III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part I. Renal, neuropsychiatric, cardiovascular, pulmonary and hematologic disease. Ann Intern Med 1995; 122: 940–50.
- 11 Ward MM, Studenski S. The time course of acute psychiatric episodes in SLE. J Rheumatol 1991; 18: 535–9.
- 12 Van Dam AP, Wekking EM, Callewaert JA, Schipperjin AJ, Oomen HA, De Jong J, et al. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int 1994; 14: 57–62.
- 13 Johnson RT, Richardson EP. The neurologic manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine (Baltimore) 1968; 47: 337–69.
- 14 Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 1979; 8: 212–21.
- 15 Hanly JG, Walsh NMG, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19: 732–41.
- 16 Kassan SS, Lockshin MD. Central nervous system lupus erythematosus: the need for classification. Arthritis Rheum 1979; 22: 1382–5.
- 17 Singer J, Denburg JA, and the Ad Hoc Neuropsychiatric Lupus Workshop Group. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. J Rheumatol 1990; 17: 1397–402.
- 18 Wulff H. Rational diagnosis and treatment. 2nd ed. Oxford: Blackwell; 1981.
- 19 Ossermann KE. Myasthenia gravis. New York: Grune and Stratton; 1958.
- 20 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 1988; 8 Suppl 7: 1–44.
- 21 Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489–501.
- 22 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
- 23 McLeod JG, Tuck RR. Disorders of the autonomic nervous system. Part I. Pathophysiology and clinical features. Part II. Investigation and treatment. Ann Neurol 1987; 21: 419–51.
- 24 Ashbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27: 521–5.
- 25 Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990; 323: 1468–72.
- 26 Mayes B, Brey RL. Evaluation and treatment of seizures in patients with systemic lupus erythematosus. J Clin Rheumatol 1996; 2: 336–45.
- 27 Bahron RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46: 878–90.
- 28 Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology 1996; 46: 1470.
- 29 Mathias CJ. Autonomic disorders and their recognition. N Engl J Med 1997; 336: 721–4.
- 30 Engel AG. Myasthenic syndromes. In: AG Engel, C Franzini Armstrong, editors. Myology. 2nd ed. New York: McGraw Hill; 1994. p. 1798–835.
- 31 Adams RD, Victor M, Hopper AH. Principles of neurology. 6th ed. New York: McGraw Hill; 1997.
- 32 Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res 1975; 12: 189–98.
- 33 Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977; 1: 385–401.
- 34 Kiernan RJ, Mueller J, Langston JW, van Dyke C. The neurobehavioral cognitive status examination: a brief but differentiated approach to cognitive assessment. Ann Intern Med 1987; 107: 481–5.
- 35 Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
- 36 Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993; 37: 753–62.
- 37 Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.
- 38 Lew RA, Corzillius M, Bae SC, Liang MH. Quantifying diagnostic agreement among physicians [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S310.
- 39 Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis. Cambridge (MA): The MIT Press; 1975.
- 40 Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons; 1986.
- 41 Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37–46.
- 42 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7.
- 43 Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
- 44 Bluestein HG, Williams GW, Steinberg AD. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981; 70: 240–6.
- 45 Temesvari A, Denburg J, Denburg S, Carbotte R, Bensen W, Singal D. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study. Clin Immunol Immunopathol 1983; 28: 243–51.
- 46 Robbins ML, Kornguth SE, Bell CL, Kalinke T, England D, Turski P, et al. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus: combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum 1988; 31: 623–31.
- 47 Costalla LTL, de Oliveira RM, Santiago MB, Cossermelli W, Samara AM. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebroside antibodies. Clin Rheumatol 1990; 9: 489–97.
- 48 Matsunaga K, Kawai T, Kato K, Tani K, Okhubo T. Antimyosin antibodies in CNS lupus. Tohoku J Exp Med 1991; 163: 211–8.
- 49 Denburg SD, Behmann SA, Carbotte RM, Denburg JA. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus: relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum 1994; 37: 369–75.
- 50 Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47–51.
- 51 Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181–9.
- 52 Brey RL, Gharavi AE, Lockshin MD. Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin North Am 1993; 19: 833–50.
- 53 Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397–401.
- 54 Bonfa E, Golombek SJ, Kaufmann LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265–71.
- 55 Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991; 90: 54–62.
- 56 Teh L-S, Isenberg DA. Antiribosomal P protein antibodies in systemic lupus erythematosus: a reappraisal. Arthritis Rheum 1994; 37: 307–15.
- 57 McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31: 159–66.
- 58 Stoppe G, Wildhagen K, Seidel JW, Meyer GJ, Schober O, Heintz P, et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990; 40: 304–8.
- 59 Miller DH, Buchanan N, Barker G, Morrisey SP, Kendall BE, Rudge P, et al. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J Neurol 1992; 239: 460–4.
- 60 Rogers MP, Waterhouse E, Nagel JS, Roberts NW, Stern SS, Fraser P, et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1: 215–9.
- 61 Stimmler MM, Coletti PM, Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 345–9.
- 62 Holman BL. Functional imaging in systemic lupus erythematosus: an accurate indicator of central nervous system involvement? Arthritis Rheum 1993; 36: 1193–5.
- 63 Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994; 37: 1609–13.
- 64 Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998; 41: 41–7.
- 65 Hanly JG. Single photon emission computed tomography scanning in neuropsychiatric systemic lupus erythematosus. J Rheumatol 1998; 25: 401–3.
- 66 Sibley JT, Olszynaski WP, Decoteau WE, Sundaram MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992; 19: 47–52.
- 67 Shortall E, Isenberg D, Newman SP. Factors associated with mood and mood disorders in SLE. Lupus 1995; 4: 272–9.
- 68 Stern M, Robbins ES. Psychoses in systemic lupus erythematosus. Arch Gen Psychiatry 1960; 3: 205–12.
- 69 O'Connor JF. Psychoses associated with systemic lupus erythematosus. Ann Intern Med 1959; 51: 526–36.
- 70 Kremer JN, Rynes RI, Bartholomew LE, Rodichok LE, Pelson EW, Block EA, et al. Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1981; 11: 182–9.
- 71 Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357–64.
- 72 Denburg SD, Carbotte RM, Denburg JA. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987; 9: 323–39.
- 73 Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7.
- 74 Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM, et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6.
- 75 Ginsburg KS, Wright EA, Larson MG, Fossel AH, Alpert M, Schur PH, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 776–82.
- 76 Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–45.
- 77 Nelson A, Fogel BS, Faust D. Bedside cognitive screening instruments: a critical assessment. J Nerv Ment Dis 1986; 174: 73–83.
- 78 Karzmark P. Operating characteristics of neurobehavioral cognitive status exam using neuropsychological assessment as the criterion. Assessment 1997; 4: 1–8.
- 79 Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press; 1991.
- 80 Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.
- 81 Isenberg DA, Meyrick-Thomas D, Snaith ML, McKeran RO, Royston JP. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982; 48: 30–2.
- 82 Kovacs JAJ, Urowitz MB, Gladman DD. Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 1993; 19: 795–814.
- 83 Molad AM, Wysenbeek AJ. Headache in systemic lupus erythematosus and its relation to disease manifestations [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S256.
- 84 Omdal R, Mellgren SI, Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol 1988; 17: 113–7.
- 85 Vazquez-Cruz J, Traboulssi H, Rodriguez-De la Serna A, Geli C, Roig C, Diaz CA. A prospective study of chronic or recurrent headache in systemic lupus erythematosus. Headache 1990; 30: 232–5.
- 86 Markus HS, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol 1992; 239: 39–42.
- 87 Atkinson RA, Appenzeller O. Headache in small vessel disease of the brain: a study of patients with systemic lupus erythematosus. Headache 1978; 15: 198–204.
- 88 Brandt KD, Lessel S. Migrainous phenomenon in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 7–16.
- 89 Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM. Headache in systemic lupus erythematosus. Br J Rheumatol 1998; 37: 300–3.
- 90 Kaplan PE, Betts HB. Lupoid sclerosis: evaluation and treatment. Arch Phys Med Rehabil 1977; 58: 24–8.
- 91 Allen IV, Miller JHD, Kirk J, Shillington RK. Systemic lupus erythematosus clinically resembling multiple sclerosis and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psychiatry 1979; 42: 392–401.
- 92 Sloan JB, Berk MA, Gebel HM, Fretzin DF. Multiple sclerosis and systemic lupus erythematosus: occurrence in two generations of the same family. Arch Intern Med 1987; 147: 1317–20.
- 93 McCombe PA, Chalk JB, Pender MP. Familial occurrence of multiple sclerosis, thyroid disease and systemic lupus erythematosus. J Neurol Sci 1990; 97: 163–71.
- 94 Kinnunen E, Muller K, Keto P, Ketonen L, Helve T, Sepponen R. Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 1993; 78: 356–60.
- 95 Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E. Lupoid sclerosis with antiphospholipid antibodies. J Rheumatol 1993; 20: 747–9.
- 96 Scott TF, Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis and systemic lupus erythematosus clinically and by magnetic resonance imaging. Arch Intern Med 1994; 154: 917–20.
- 97 Rolak LA. The diagnosis of multiple sclerosis. Neurol Clin 1996; 14: 27–43.
- 98 Trapp BD, Peterson J, Ransohoff RM, Rudick R, Moerk S, Boe L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278–85.
- 99
Donaldson I,
Mac G,
Espiner EA.
Disseminated lupus erythematosus presenting as chorea gravidarum.
Arch Neurol
1971;
24:
240–4.
10.1001/archneur.1971.00490030066007 Google Scholar
- 100 Groothuis JR, Mukopadhyay D, Grossman BJ, Altemeier WA. Lupus-associated chorea in childhood. Am J Dis Child 1977; 131: 1131–4.
- 101 Bruyn GW, Padberg G. Chorea and lupus erythematosus: a critical review. Eur Neurol 1984; 23: 435–48.
- 102 Penn AS, Rowan AJ. Myelopathy in systemic lupus erythematosus. Arch Neurol 1968; 18: 337–49.
- 103 Warren RW, Kredich DW. Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1984; 27: 1058–60.
- 104 Sands ML, Ryczak M, Brown RB. Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J Rheumatol 1988; 15: 862–4.
- 105 Boumpas DT, Patronas AJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 1990; 17: 89–92.
- 106 Watanabe T, Satoh M, Abe T, Hayashi M, Oda Y. Stroke and meningitis in a case of SLE with anti-phospholipid antibodies. Acta Paediatr Jpn 1993; 35: 423–5.
- 107 Feinglass EJ, Arnett FC, Dorsch CA, Zizic M, Stevens MB. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to other features of disease. Medicine (Baltimore) 1976; 55: 323–39.
- 108 Ribaute E, Weill B, Ing H, Badelon I, Menkes CJ. Oculomotor paralysis in disseminated lupus erythematosus. Ophthalmologie 1989; 3: 125–8.
- 109 Lundberg PO, Werner I. Trigeminal sensory neuropathy in systemic lupus erythematosus. Acta Neurol Scand 1972; 48: 330–40.
- 110 Rosenstein ED, Sobelmann J, Kramer N. Isolated, pupil-sparing third nerve palsy as initial manifestation of systemic lupus erythematosus. J Clin Neuro-Ophthalmol 1989; 9: 285–9.
- 111 Hughes RA, Cameron JS, Hall SM, Heaton J, Payan J, Tech R. Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus—nerve biopsy and response to plasma exchange. J Neurol 1982; 228: 239–47.
- 112 Block SL, Jarrett MP, Swerdlow M, Grayzel AI. Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus. Neurology 1979; 29: 1633–4.
- 113 Assal F, Blanche P, Lamy C, Sicard D, de Recondo J. Involvement of the brachial plexus in a patient with systemic lupus erythematosus [letter]. Presse Med 1993; 22: 598.
- 114 McCombe PA, McLeod JG, Pollard JD, Guo YP, Ingall TJ. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus: clinical, pathological, and immunological features. Brain 1987; 110: 533–49.
- 115 Scheinberg L. Polyneuritis in systemic lupus erythematosus: review of the literature and report of a case. N Engl J Med 1956; 255: 416–21.
- 116 Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 1985; 44: 420–4.
- 117 Omdal R, Jorde R, Mellgren SI, Husby G. Autonomic function in systemic lupus erythematosus. Lupus 1994; 3: 413–7.
- 118 Liote F, Osterland CK. Autonomic neuropathy in systemic lupus erythematosus: cardiovascular autonomic function assessment. Ann Rheum Dis 1994; 53: 671–4.
- 119 Killian PJ, Hoffman GS. Coexistence of systemic lupus erythematosus and myasthenia gravis. South Med J 1980; 73: 244–6.
- 120 Ciaccio M, Parodi A, Regora A. Myasthenia gravis and systemic lupus erythematosus. Int J Dermatol 1989; 28: 317–21.
- 121 Milette TJ, Subramony SH, Wee AS, Harisdangkul V. Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy. Eur Neurol 1986; 25: 397–402.
- 122 Morgan SH, Kennet RP, Dudley C, Mackworth-Young C, Hull R, Hughes GR. Acute polyradiculoneuropathy complicating systemic lupus erythematosus. Postgrad Med J 1986; 62: 291–4.
- 123 Robson MG, Walport MJ, Davies KA. Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol 1991; 30: 314–6.
